• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1 gp41 氨基端七肽重复区的保守残基 Arg46 对病毒融合和进入至关重要。

The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entry.

机构信息

Key Laboratory of Tropical Disease Control of MOE, Department of Biochemistry and The Institute of Human Virology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.

出版信息

PLoS One. 2012;7(9):e44874. doi: 10.1371/journal.pone.0044874. Epub 2012 Sep 7.

DOI:10.1371/journal.pone.0044874
PMID:22970321
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3436870/
Abstract

During the process of HIV-1 fusion with the target cell, the N-terminal heptad repeat (NHR) of gp41 interacts with the C-terminal heptad repeat (CHR) to form fusogenic six-helix bundle (6-HB) core. We previously identified a crucial residue for 6-HB formation and virus entry--Lys63 (K63) in the C-terminal region of NHR (aa 54-70), which forms a hydrophobic cavity. It can form an important salt bridge with Asp121 (D121) in gp41 CHR. Here, we found another important conserved residue for virus fusion and entry, Arg46 (R46), in the N-terminal region of NHR (aa 35-53), which forms a hydrogen bond with a polar residue, Asn43 (N43), in NHR, as a part of the hydrogen-bond network. R46 can also form a salt bridge with a negatively charged residue, Glu137 (E137), in gp41 CHR. Substitution of R46 with the hydrophobic residue Ala (R46A) or the negatively charged residue Glu (R46E) resulted in disruption of the hydrogen bond network, breakage of the salt bridge and reduction of 6-HB's stability, leading to impairment of viral fusion and decreased inhibition of N36, an NHR peptide. Similarly, CHR peptide C34 with substitution of E137 for Ala (E137A) or Arg (E137R) also exhibited reduced inhibitory activity against HIV-1 infection and HIV-1-mediated cell-to-cell fusion. These results suggest that the positively charged residue R46 and its hydrogen bond network, together with the salt bridge between R46 and E137, are important for viral fusion and entry and may therefore serve as a target for designing novel HIV fusion/entry inhibitors.

摘要

在 HIV-1 与靶细胞融合的过程中,gp41 的 N 端七肽重复(NHR)与 C 端七肽重复(CHR)相互作用形成融合六螺旋束(6-HB)核心。我们之前确定了 6-HB 形成和病毒进入的关键残基——NHR(aa54-70)C 端区域的 Lys63(K63),它形成一个疏水性腔。它可以与 gp41 CHR 中的 Asp121(D121)形成重要的盐桥。在这里,我们发现 NHR N 端的另一个对病毒融合和进入很重要的保守残基——Arg46(R46)(aa35-53),它与 NHR 中的极性残基 Asn43(N43)形成氢键,作为氢键网络的一部分。R46 还可以与 gp41 CHR 中的带负电荷的残基 Glu137(E137)形成盐桥。用疏水性残基 Ala(R46A)或带负电荷的残基 Glu(R46E)取代 R46,会破坏氢键网络,破坏盐桥,降低 6-HB 的稳定性,从而损害病毒融合,并降低 NHR 肽 N36 的抑制作用。同样,用 Ala(E137A)或 Arg(E137R)取代 CHR 肽 C34 中的 E137,也表现出对 HIV-1 感染和 HIV-1 介导的细胞间融合的抑制活性降低。这些结果表明,带正电荷的残基 R46 及其氢键网络,以及 R46 和 E137 之间的盐桥,对病毒融合和进入很重要,因此可能成为设计新型 HIV 融合/进入抑制剂的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/5ee535ce2e20/pone.0044874.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/2982d3ceb2b5/pone.0044874.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/39a1aebfe540/pone.0044874.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/8333682bd206/pone.0044874.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/4db308d0e1db/pone.0044874.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/5ee535ce2e20/pone.0044874.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/2982d3ceb2b5/pone.0044874.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/39a1aebfe540/pone.0044874.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/8333682bd206/pone.0044874.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/4db308d0e1db/pone.0044874.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c01a/3436870/5ee535ce2e20/pone.0044874.g005.jpg

相似文献

1
The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entry.HIV-1 gp41 氨基端七肽重复区的保守残基 Arg46 对病毒融合和进入至关重要。
PLoS One. 2012;7(9):e44874. doi: 10.1371/journal.pone.0044874. Epub 2012 Sep 7.
2
Conserved salt bridge between the N- and C-terminal heptad repeat regions of the human immunodeficiency virus type 1 gp41 core structure is critical for virus entry and inhibition.人类免疫缺陷病毒1型gp41核心结构的N端和C端七肽重复区域之间保守的盐桥对病毒进入和抑制至关重要。
J Virol. 2008 Nov;82(22):11129-39. doi: 10.1128/JVI.01060-08. Epub 2008 Sep 3.
3
Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry.HIV-1 Gp41卷曲螺旋结构域腔内保守残基Lys574对六螺旋束稳定性和病毒进入至关重要。
J Biol Chem. 2007 Aug 31;282(35):25631-9. doi: 10.1074/jbc.M703781200. Epub 2007 Jul 6.
4
HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides.HIV gp41 C末端七肽重复序列包含多功能结构域。与抗HIV肽作用机制的关系。
J Biol Chem. 2007 Mar 30;282(13):9612-9620. doi: 10.1074/jbc.M609148200. Epub 2007 Feb 2.
5
The Tryptophan-Rich Motif of HIV-1 gp41 Can Interact with the N-Terminal Deep Pocket Site: New Insights into the Structure and Function of gp41 and Its Inhibitors.HIV-1 gp41 富含色氨酸基序可与 N 端深袋位结合:对 gp41 结构与功能及其抑制剂的新认识。
J Virol. 2019 Dec 12;94(1). doi: 10.1128/JVI.01358-19.
6
Identification of a critical motif for the human immunodeficiency virus type 1 (HIV-1) gp41 core structure: implications for designing novel anti-HIV fusion inhibitors.鉴定人类免疫缺陷病毒1型(HIV-1)gp41核心结构的关键基序:对设计新型抗HIV融合抑制剂的意义。
J Virol. 2008 Jul;82(13):6349-58. doi: 10.1128/JVI.00319-08. Epub 2008 Apr 16.
7
HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket- or membrane-binding domain.在gp41口袋区域具有单点突变的HIV-1变体,对具有口袋或膜结合结构域的HIV融合抑制剂表现出不同的敏感性。
Biochim Biophys Acta. 2012 Dec;1818(12):2950-7. doi: 10.1016/j.bbamem.2012.07.020. Epub 2012 Jul 31.
8
Hydrophobic mutations in buried polar residues enhance HIV-1 gp41 N-terminal heptad repeat-C-terminal heptad repeat interactions and C-peptides' anti-HIV activity.埋藏极性残基的疏水性突变增强了 HIV-1 gp41 N 端七肽重复 - C 端七肽重复相互作用和 C 肽的抗 HIV 活性。
AIDS. 2014 Jun 1;28(9):1251-60. doi: 10.1097/QAD.0000000000000255.
9
Conserved Residue Asn-145 in the C-Terminal Heptad Repeat Region of HIV-1 gp41 is Critical for Viral Fusion and Regulates the Antiviral Activity of Fusion Inhibitors.HIV-1 gp41 衣壳蛋白 C 端七肽重复区的保守残基 Asn-145 对病毒融合至关重要,并调节融合抑制剂的抗病毒活性。
Viruses. 2019 Jul 3;11(7):609. doi: 10.3390/v11070609.
10
ADS-J1 inhibits HIV-1 infection and membrane fusion by targeting the highly conserved pocket in the gp41 NHR-trimer.ADS-J1通过靶向gp41 NHR三聚体中高度保守的口袋区域来抑制HIV-1感染和膜融合。
Biochim Biophys Acta. 2014 May;1838(5):1296-305. doi: 10.1016/j.bbamem.2013.12.022. Epub 2014 Jan 3.

引用本文的文献

1
Heptad stereotypy, S/Q layering, and remote origin of the SARS-CoV-2 fusion core.严重急性呼吸综合征冠状病毒2融合核心的七肽重复序列保守性、S/Q分层及远源起源
Virus Evol. 2021 Dec 15;7(2):veab097. doi: 10.1093/ve/veab097. eCollection 2022 Jan.
2
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China.针对源自中国武汉的肺炎疫情的新型冠状病毒感染的诊断和治疗措施。
Microbes Infect. 2020 Mar;22(2):74-79. doi: 10.1016/j.micinf.2020.01.003. Epub 2020 Feb 1.
3
Molecular dynamics modeling the synthetic and biological polymers interactions pre-studied via docking: anchors modified polyanions interference with the HIV-1 fusion mediator.

本文引用的文献

1
Alanine scanning mutagenesis of HIV-1 gp41 heptad repeat 1: insight into the gp120-gp41 interaction.HIV-1 gp41 七肽重复 1 的丙氨酸扫描诱变:gp120-gp41 相互作用的深入了解。
Biochemistry. 2010 Jun 22;49(24):5057-65. doi: 10.1021/bi1005267.
2
The role of amphiphilicity and negative charge in glycoprotein 41 interactions in the hydrophobic pocket.两亲性和负电荷在糖蛋白41于疏水口袋中相互作用的作用。
J Med Chem. 2009 Jul 23;52(14):4338-44. doi: 10.1021/jm900190q.
3
Combinations of the first and next generations of human immunodeficiency virus (HIV) fusion inhibitors exhibit a highly potent synergistic effect against enfuvirtide- sensitive and -resistant HIV type 1 strains.
通过对接预先研究合成聚合物与生物聚合物相互作用的分子动力学建模:锚定修饰的聚阴离子对HIV-1融合介质的干扰
J Comput Aided Mol Des. 2014 Jun;28(6):647-73. doi: 10.1007/s10822-014-9749-8. Epub 2014 May 27.
第一代和下一代人类免疫缺陷病毒(HIV)融合抑制剂的组合对恩夫韦肽敏感和耐药的1型HIV毒株具有高效的协同作用。
J Virol. 2009 Aug;83(16):7862-72. doi: 10.1128/JVI.00168-09. Epub 2009 Jun 3.
4
Conserved residue Lys574 in the cavity of HIV-1 Gp41 coiled-coil domain is critical for six-helix bundle stability and virus entry.HIV-1 Gp41卷曲螺旋结构域腔内保守残基Lys574对六螺旋束稳定性和病毒进入至关重要。
J Biol Chem. 2007 Aug 31;282(35):25631-9. doi: 10.1074/jbc.M703781200. Epub 2007 Jul 6.
5
HIV gp41 C-terminal heptad repeat contains multifunctional domains. Relation to mechanisms of action of anti-HIV peptides.HIV gp41 C末端七肽重复序列包含多功能结构域。与抗HIV肽作用机制的关系。
J Biol Chem. 2007 Mar 30;282(13):9612-9620. doi: 10.1074/jbc.M609148200. Epub 2007 Feb 2.
6
Pharmacokinetics of sifuvirtide, a novel anti-HIV-1 peptide, in monkeys and its inhibitory concentration in vitro.新型抗HIV-1肽西夫韦肽在猴体内的药代动力学及其体外抑制浓度
Acta Pharmacol Sin. 2005 Oct;26(10):1274-80. doi: 10.1111/j.1745-7254.2005.00163.x.
7
Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.HIV gp41 N区域卷曲螺旋的共价稳定作用产生了极其强效且广谱的病毒感染抑制剂。
Proc Natl Acad Sci U S A. 2005 Sep 6;102(36):12903-8. doi: 10.1073/pnas.0502449102. Epub 2005 Aug 29.
8
The fusion activity of HIV-1 gp41 depends on interhelical interactions.HIV-1 gp41的融合活性取决于螺旋间的相互作用。
J Biol Chem. 2005 May 20;280(20):19852-7. doi: 10.1074/jbc.M502196200. Epub 2005 Mar 16.
9
Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120.与HIV融合抑制剂C34不同,抗HIV药物福泽昂(T-20)通过靶向gp41和gp120中的多个位点来抑制HIV-1进入。
J Biol Chem. 2005 Mar 25;280(12):11259-73. doi: 10.1074/jbc.M411141200. Epub 2005 Jan 7.
10
N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.N-取代吡咯衍生物作为新型1型人类免疫缺陷病毒进入抑制剂,可干扰gp41六螺旋束的形成并阻断病毒融合。
Antimicrob Agents Chemother. 2004 Nov;48(11):4349-59. doi: 10.1128/AAC.48.11.4349-4359.2004.